Advanced company searchLink opens in new window

CIDARA THERAPEUTICS UK LIMITED

Company number 10054750

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
18 Mar 2024 CS01 Confirmation statement made on 9 March 2024 with no updates
05 Mar 2024 AA Accounts for a dormant company made up to 31 December 2023
23 Jun 2023 AA Accounts for a dormant company made up to 31 December 2022
18 Apr 2023 CS01 Confirmation statement made on 9 March 2023 with no updates
03 Oct 2022 AA Accounts for a dormant company made up to 31 December 2021
22 Mar 2022 CS01 Confirmation statement made on 9 March 2022 with no updates
27 Oct 2021 AP01 Appointment of Shane Michael Ward as a director on 25 August 2021
27 Oct 2021 TM01 Termination of appointment of Jessica Oien as a director on 6 August 2021
27 Sep 2021 AA Accounts for a dormant company made up to 31 December 2020
12 Mar 2021 CS01 Confirmation statement made on 9 March 2021 with no updates
28 Jan 2021 AA Accounts for a dormant company made up to 31 December 2019
12 Mar 2020 CS01 Confirmation statement made on 9 March 2020 with no updates
08 May 2019 AA Accounts for a dormant company made up to 31 December 2018
12 Mar 2019 CS01 Confirmation statement made on 9 March 2019 with no updates
31 Oct 2018 TM01 Termination of appointment of Matthew William Onaitis as a director on 17 August 2018
17 Oct 2018 AP01 Appointment of Jessica Oien as a director on 12 October 2018
11 Jun 2018 AA Accounts for a dormant company made up to 31 December 2017
13 Mar 2018 CS01 Confirmation statement made on 9 March 2018 with no updates
16 Oct 2017 PSC02 Notification of Cidara Therapeutics, Inc. as a person with significant control on 6 April 2016
16 Oct 2017 PSC09 Withdrawal of a person with significant control statement on 16 October 2017
09 Oct 2017 AA Accounts for a dormant company made up to 31 December 2016
20 Mar 2017 CS01 Confirmation statement made on 9 March 2017 with updates
17 Nov 2016 AP01 Appointment of Matthew William Onaitis as a director on 11 November 2016
16 Nov 2016 TM01 Termination of appointment of Kevin Forrest as a director on 11 November 2016
15 Mar 2016 AA01 Current accounting period shortened from 31 March 2017 to 31 December 2016